Urszula Fraczek

Title: Urszula Fraczek: Innovator in Pharmaceutical Chemistry

Introduction

Urszula Fraczek is a notable inventor based in Marki, Poland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and their synthesis. With a total of 2 patents, her work has implications for the treatment of various medical conditions.

Latest Patents

Urszula's latest patents include innovative methods and compounds that enhance pharmaceutical formulations. One of her key inventions is related to crystalline polymorphs of methanesulfonic acid addition salts of Imatinib. This invention focuses on the synthesis of the crystalline α-form of Imatinib methanesulfonate, along with a novel acid addition salt of a specific compound with methanesulfonic acid. Additionally, she has developed methods for the preparation of olanzapine polymorphic Form I, which includes new mixed solvates of olanzapine that serve as valuable intermediates in the production of pure olanzapine polymorphic Form I.

Career Highlights

Throughout her career, Urszula has worked with esteemed organizations such as the Pharmaceutical Institute and the Pharmaceutical Institute. Her expertise in pharmaceutical chemistry has allowed her to contribute to advancements in drug formulation and development.

Collaborations

Urszula has collaborated with notable colleagues, including Magdalena Glice and Wieslaw Szelejewski. These partnerships have fostered a collaborative environment that enhances innovation in her field.

Conclusion

Urszula Fraczek's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact the development of effective pharmaceutical compounds.